Oncidium foundation's CEO, Rebecca Lo bue, represented the foundation at the European Parliament on April 9th during the panel discussion “European and National RLT Policy & Reality”, co-hosted by MEPs Tomislav Sokol and Nicholas Papandreou.

Rebecca highlighted the critical need to overcome real-world barriers to access in Radioligand Therapy (RLT), including reimbursement, awareness, infrastructure, and patient-centric support. She shared examples of disparities across Europe and called for 𝗵𝗮𝗿𝗺𝗼𝗻𝗶𝘇𝗲𝗱 𝗿𝗲𝗳𝗲𝗿𝗿𝗮𝗹 𝗽𝗮𝘁𝗵𝘄𝗮𝘆𝘀, 𝗰𝗿𝗼𝘀𝘀-𝗯𝗼𝗿𝗱𝗲𝗿 𝗰𝗼𝗹𝗹𝗮𝗯𝗼𝗿𝗮𝘁𝗶𝗼𝗻, 𝗮𝗻𝗱 𝘁𝗮𝗿𝗴𝗲𝘁𝗲𝗱 𝗶𝗻𝘃𝗲𝘀𝘁𝗺𝗲𝗻𝘁 𝗶𝗻 𝗻𝘂𝗰𝗹𝗲𝗮𝗿 𝗺𝗲𝗱𝗶𝗰𝗶𝗻𝗲 to ensure every patient benefits from these innovative therapies.

We sincerely thank SPARC Europe for inviting us to join this important discussion on patient access to Radioligand Therapy.